AAPL323.85-3.89 (-1.19%) ▼|ABBV253.46-2.65 (-1.03%) ▼|ABT100.82+1.15 (+1.15%) ▲|ACN139.77-1.10 (-0.78%) ▼|ADBE220.19-6.98 (-3.07%) ▼|AMAT560.42-4.13 (-0.73%) ▼|AMD553.93+9.50 (+1.74%) ▲|AMGN367.44+1.20 (+0.33%) ▲|AMT166.14+2.75 (+1.68%) ▲|AMZN242.86-4.69 (-1.89%) ▼|AVGO396.13+9.63 (+2.49%) ▲|AXP348.86-1.94 (-0.55%) ▼|BA209.04+4.24 (+2.07%) ▲|BAC61.61+0.39 (+0.63%) ▲|BKNG179.21-0.19 (-0.11%) ▼|BLK1,044.79+6.55 (+0.63%) ▲|BMY60.84-0.10 (-0.16%) ▼|BNY159.81+0.92 (+0.58%) ▲|BRK-B489.28-0.37 (-0.08%) ▼|C132.83-0.01 (-0.01%) ▼|CAT898.25+8.28 (+0.93%) ▲|CL91.90+1.40 (+1.55%) ▲|CMCSA23.67-0.14 (-0.60%) ▼|COF201.62-4.60 (-2.23%) ▼|COP119.28+1.78 (+1.51%) ▲|COST924.51-4.72 (-0.51%) ▼|CRM162.70-7.36 (-4.33%) ▼|CSCO112.68+0.50 (+0.45%) ▲|CVS109.65-0.96 (-0.86%) ▼|CVX192.90+1.83 (+0.96%) ▲|DE608.21+21.33 (+3.63%) ▲|DHR177.48-1.53 (-0.85%) ▼|DIS96.47+0.33 (+0.34%) ▲|DUK127.86+1.95 (+1.55%) ▲|EMR139.90+0.64 (+0.46%) ▲|FDX319.12+3.93 (+1.25%) ▲|GD372.94+5.21 (+1.42%) ▲|GE341.95+1.25 (+0.37%) ▲|GEV993.30-85.51 (-7.93%) ▼|GILD131.50+1.22 (+0.94%) ▲|GM82.09+2.57 (+3.23%) ▲|GOOG345.87-0.32 (-0.09%) ▼|GOOGL346.53-0.62 (-0.18%) ▼|GS1,095.69+10.13 (+0.93%) ▲|HD332.81+1.21 (+0.36%) ▲|HON232.25+2.39 (+1.04%) ▲|IBM205.66-4.85 (-2.30%) ▼|INTC104.00-1.46 (-1.38%) ▼|INTU285.60-4.32 (-1.49%) ▼|ISRG343.74-6.33 (-1.81%) ▼|JNJ254.66+4.05 (+1.61%) ▲|JPM347.31+2.08 (+0.60%) ▲|KO82.55+0.58 (+0.70%) ▲|LIN510.57+5.54 (+1.10%) ▲|LLY1,163.58-11.84 (-1.01%) ▼|LMT516.18+9.09 (+1.79%) ▲|LOW204.00+1.74 (+0.86%) ▲|LRCX321.50-0.50 (-0.16%) ▼|MA533.26-5.04 (-0.94%) ▼|MCD264.20+0.29 (+0.11%) ▲|MDLZ60.82+0.96 (+1.60%) ▲|MDT81.82-0.54 (-0.65%) ▼|META626.35-17.46 (-2.71%) ▼|MMM170.45-0.32 (-0.18%) ▼|MO72.65-0.34 (-0.47%) ▼|MRK127.80+1.54 (+1.22%) ▲|MS218.35+1.95 (+0.90%) ▲|MSFT387.97-9.78 (-2.46%) ▼|MU971.29+0.47 (+0.05%) ▲|NEE89.60+1.67 (+1.90%) ▲|NFLX69.26+0.59 (+0.86%) ▲|NKE41.96-1.00 (-2.33%) ▼|NOW95.26-6.80 (-6.66%) ▼|NVDA213.69+6.40 (+3.09%) ▲|ORCL125.01-2.04 (-1.61%) ▼|PEP136.07+1.07 (+0.79%) ▲|PFE24.93-0.02 (-0.06%) ▼|PG149.76+1.66 (+1.12%) ▲|PLTR123.84-8.82 (-6.65%) ▼|PM192.80+4.76 (+2.53%) ▲|QCOM176.03+2.53 (+1.46%) ▲|RTX194.83+1.16 (+0.60%) ▲|SBUX104.17-0.28 (-0.27%) ▼|SCHW100.33+0.37 (+0.37%) ▲|SO95.54+1.69 (+1.80%) ▲|SPG226.82+0.03 (+0.01%) ▲|T23.03+0.77 (+3.44%) ▲|TMO524.26+0.80 (+0.15%) ▲|TMUS191.92+1.15 (+0.60%) ▲|TSLA375.83-3.11 (-0.82%) ▼|TXN294.06+2.76 (+0.95%) ▲|UBER70.45-1.10 (-1.54%) ▼|UNH434.68-1.67 (-0.38%) ▼|UNP293.46+0.33 (+0.11%) ▲|UPS116.44+0.10 (+0.09%) ▲|USB64.07+0.36 (+0.56%) ▲|V354.01-1.81 (-0.51%) ▼|VZ44.46+0.68 (+1.54%) ▲|WFC86.37-1.37 (-1.56%) ▼|WMT109.21-1.19 (-1.07%) ▼|XOM154.45+2.74 (+1.81%) ▲|AAPL323.85-3.89 (-1.19%) ▼|ABBV253.46-2.65 (-1.03%) ▼|ABT100.82+1.15 (+1.15%) ▲|ACN139.77-1.10 (-0.78%) ▼|ADBE220.19-6.98 (-3.07%) ▼|AMAT560.42-4.13 (-0.73%) ▼|AMD553.93+9.50 (+1.74%) ▲|AMGN367.44+1.20 (+0.33%) ▲|AMT166.14+2.75 (+1.68%) ▲|AMZN242.86-4.69 (-1.89%) ▼|AVGO396.13+9.63 (+2.49%) ▲|AXP348.86-1.94 (-0.55%) ▼|BA209.04+4.24 (+2.07%) ▲|BAC61.61+0.39 (+0.63%) ▲|BKNG179.21-0.19 (-0.11%) ▼|BLK1,044.79+6.55 (+0.63%) ▲|BMY60.84-0.10 (-0.16%) ▼|BNY159.81+0.92 (+0.58%) ▲|BRK-B489.28-0.37 (-0.08%) ▼|C132.83-0.01 (-0.01%) ▼|CAT898.25+8.28 (+0.93%) ▲|CL91.90+1.40 (+1.55%) ▲|CMCSA23.67-0.14 (-0.60%) ▼|COF201.62-4.60 (-2.23%) ▼|COP119.28+1.78 (+1.51%) ▲|COST924.51-4.72 (-0.51%) ▼|CRM162.70-7.36 (-4.33%) ▼|CSCO112.68+0.50 (+0.45%) ▲|CVS109.65-0.96 (-0.86%) ▼|CVX192.90+1.83 (+0.96%) ▲|DE608.21+21.33 (+3.63%) ▲|DHR177.48-1.53 (-0.85%) ▼|DIS96.47+0.33 (+0.34%) ▲|DUK127.86+1.95 (+1.55%) ▲|EMR139.90+0.64 (+0.46%) ▲|FDX319.12+3.93 (+1.25%) ▲|GD372.94+5.21 (+1.42%) ▲|GE341.95+1.25 (+0.37%) ▲|GEV993.30-85.51 (-7.93%) ▼|GILD131.50+1.22 (+0.94%) ▲|GM82.09+2.57 (+3.23%) ▲|GOOG345.87-0.32 (-0.09%) ▼|GOOGL346.53-0.62 (-0.18%) ▼|GS1,095.69+10.13 (+0.93%) ▲|HD332.81+1.21 (+0.36%) ▲|HON232.25+2.39 (+1.04%) ▲|IBM205.66-4.85 (-2.30%) ▼|INTC104.00-1.46 (-1.38%) ▼|INTU285.60-4.32 (-1.49%) ▼|ISRG343.74-6.33 (-1.81%) ▼|JNJ254.66+4.05 (+1.61%) ▲|JPM347.31+2.08 (+0.60%) ▲|KO82.55+0.58 (+0.70%) ▲|LIN510.57+5.54 (+1.10%) ▲|LLY1,163.58-11.84 (-1.01%) ▼|LMT516.18+9.09 (+1.79%) ▲|LOW204.00+1.74 (+0.86%) ▲|LRCX321.50-0.50 (-0.16%) ▼|MA533.26-5.04 (-0.94%) ▼|MCD264.20+0.29 (+0.11%) ▲|MDLZ60.82+0.96 (+1.60%) ▲|MDT81.82-0.54 (-0.65%) ▼|META626.35-17.46 (-2.71%) ▼|MMM170.45-0.32 (-0.18%) ▼|MO72.65-0.34 (-0.47%) ▼|MRK127.80+1.54 (+1.22%) ▲|MS218.35+1.95 (+0.90%) ▲|MSFT387.97-9.78 (-2.46%) ▼|MU971.29+0.47 (+0.05%) ▲|NEE89.60+1.67 (+1.90%) ▲|NFLX69.26+0.59 (+0.86%) ▲|NKE41.96-1.00 (-2.33%) ▼|NOW95.26-6.80 (-6.66%) ▼|NVDA213.69+6.40 (+3.09%) ▲|ORCL125.01-2.04 (-1.61%) ▼|PEP136.07+1.07 (+0.79%) ▲|PFE24.93-0.02 (-0.06%) ▼|PG149.76+1.66 (+1.12%) ▲|PLTR123.84-8.82 (-6.65%) ▼|PM192.80+4.76 (+2.53%) ▲|QCOM176.03+2.53 (+1.46%) ▲|RTX194.83+1.16 (+0.60%) ▲|SBUX104.17-0.28 (-0.27%) ▼|SCHW100.33+0.37 (+0.37%) ▲|SO95.54+1.69 (+1.80%) ▲|SPG226.82+0.03 (+0.01%) ▲|T23.03+0.77 (+3.44%) ▲|TMO524.26+0.80 (+0.15%) ▲|TMUS191.92+1.15 (+0.60%) ▲|TSLA375.83-3.11 (-0.82%) ▼|TXN294.06+2.76 (+0.95%) ▲|UBER70.45-1.10 (-1.54%) ▼|UNH434.68-1.67 (-0.38%) ▼|UNP293.46+0.33 (+0.11%) ▲|UPS116.44+0.10 (+0.09%) ▲|USB64.07+0.36 (+0.56%) ▲|V354.01-1.81 (-0.51%) ▼|VZ44.46+0.68 (+1.54%) ▲|WFC86.37-1.37 (-1.56%) ▼|WMT109.21-1.19 (-1.07%) ▼|XOM154.45+2.74 (+1.81%) ▲|
30.3 C
New York
Wednesday, July 22, 2026

Tag: regulator

Abaxx Continues to Provide Facts Refuting Ongoing Misinformation and Reaffirms Strong Business Fundamentals

Abaxx continues to provide facts refuting ongoing misinformation, reaffirms strong business fundamentals, and confirms potential litigation.

WASKAHIGAN OIL & GAS CORP. ANNOUNCES PRIVATE PLACEMENT

/NOT FOR DISSEMINATION IN THE U.S. OR FOR DISTIRBUTION TO THE U.S. NEWS WIRE SERVICES/CALGARY, AB, June 18, 2026 /CNW/ - Waskahigan Oil &...

Premier Health of America Provides Update on Management Cease Trade Order

MONTREAL, June 17, 2026 (GLOBE NEWSWIRE) -- PREMIER HEALTH OF AMERICA INC. (TSX-V: PHA) (“Premier Health”, or the “Company”) is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).

BIFOX ENTERS INTO AGREEMENTS TO ACQUIRE THE 550 MILLION TONNE[1] BAYOVAR 9 PHOSPHATE ROCK PROJECT IN PERU POSITIONING BIFOX TO BECOME ONE OF THE...

SYDNEY, June 15, 2026 /PRNewswire/ -- Bifox Limited ("Bifox") is pleased to advise it has entered into two agreements with Fossal S.A.A ("Fossal"), to...

Futu Investor News: If You Have Suffered Losses in Futu Holdings Limited (NASDAQ: FUTU), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 13, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public.

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.

Carbon Streaming Announces Annual General Meeting Results

Carbon Streaming Announces Annual General Meeting Results

Imperial pleads guilty to EPEA violation in Crown’s summary disposition on Kearl

Fort McMurray, AB, June 11, 2026 (GLOBE NEWSWIRE) -- Imperial Oil Resources Limited (Imperial) pled guilty in the Alberta Court of Justice at a May 29 hearing to contravening a term or condition of its Environmental Protection and Enhancement Act (EPEA) approval, which is considered an offence under section 227 (e) of EPEA.

Replenish Nutrients to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub

OKOTOKS, AB, June 10, 2026 /CNW/ - Replenish Nutrients Holding Corp. (CSE: ERTH) (OTC: VVIVF) ("Replenish" or the "Company"), is pleased to announce that it...

STATEMENT – Feds prioritize kids over big tech profits: CMA

OTTAWA, ON, June 10, 2026 /CNW/ - The giants of tech and online media have been mining profit from the attention of Canadian kids for...

Ascendis to Showcase Advances in Treatment of Rare Endocrine Diseases at ENDO 2026

COPENHAGEN, Denmark, June 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its Endocrinology Rare Disease programs in hypoparathyroidism, achondroplasia, and pediatric growth hormone deficiency will be shared in two oral presentations and three posters at ENDO 2026, the annual meeting of the Endocrine Society being held in Chicago from June 13-16, 2026.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulator